The post Medline Soars 30% After $6.26 Billion IPO appeared on BitcoinEthereumNews.com. Topline Medical supply firm Medline’s stock price rose around 30% on WednesdayThe post Medline Soars 30% After $6.26 Billion IPO appeared on BitcoinEthereumNews.com. Topline Medical supply firm Medline’s stock price rose around 30% on Wednesday

Medline Soars 30% After $6.26 Billion IPO

Topline

Medical supply firm Medline’s stock price rose around 30% on Wednesday after debuting on the Nasdaq, after raising $6.26 billion on Tuesday for the largest initial public offering of the year.

Medline CEO Jim Boyle speaks before ringing the opening bell at the Nasdaq on Wednesday.

Getty Images

Key Facts

Medline’s shares were trading at $37.91 on Wednesday afternoon, up 30% after opening at $35 per share.

The medical supplies distributor sold Class A common stock for $29 per share in its initial public offering on Tuesday.

Medline sold about 216 million shares on Tuesday, raising approximately $6.26 billion.

Surprising Fact

Medline’s IPO surpassed the previous largest IPO of the year: Chinese battery maker Contemporary Amperex Technology, or CATL, which raised about $5.3 billion in May. It’s also the largest IPO for an American company since electric car manufacturer Rivian’s IPO in November 2021, which saw the company raise $11.9 billion.

Read More

Source: https://www.forbes.com/sites/zacharyfolk/2025/12/17/medline-stock-jumps-about-29-following-years-largest-ipo/

Market Opportunity
Oasis Logo
Oasis Price(ROSE)
$0.0108
$0.0108$0.0108
-4.76%
USD
Oasis (ROSE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.